The Foundation for Peripheral Neuropathy (FPN) asked Dr. Shanna Patterson and Dr. Rory Abrams, FPN’s Patient Education Advisors, what they are seeing in relation to neurological symptoms following COVID-19.
FPN recently hosted a webinar featuring speakers Lars Oddsson PhD and Lara Jacobs PT/DPT from RxFunction on the challenges that many patients with peripheral neuropathy face as they manage the all-important issues related to balance.
Additional webinars will be offered throughout 2020 and into 2021. For more information on these programs and to register, please visit our Events Webpage.
Spinal Cord Stimulation Cuts Chronic Pain and Opioid Use
Spinal cord stimulation decreased pain in patients with chronic pain for more than a year, researchers reported, and also led to a decrease in these patients’ use of opioids for pain control, a researcher reported.
From October 13 through October 14, two epic days of deals and promotions will occur on Amazon that will help support FPN. You can make a difference while you shop Amazon Prime Day deals today and tomorrow. Simply shop at smile.amazon.com/ch/26-1195248 and AmazonSmile donates to the Foundation for Peripheral Neuropathy.
MediciNova Reports Data from MN-166 Trial for Peripheral Neuropathy
MediciNova Inc. (MNOV) announced results from its trial involving MN-166 for treating chemotherapy induced peripheral neuropathy.